Breathe Well Live Well
|
NIH-Funded Scientists Identify Receptor for Asthma-Associated Virus
Infection Control Today Scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have identified a cellular receptor for rhinovirus C, a cold-causing virus that is strongly associated with severe asthma … |
View full post on asthma – Google News
|
Public Release: 6-Apr-2015 NIH-funded scientists identify receptor for asthma …
EurekAlert (press release) Scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have identified a cellular receptor for rhinovirus C, a cold-causing virus that is strongly associated with severe asthma … |
View full post on asthma – Google News
|
NIH-Funded Study Aims to Improve Medication Adherence Using Motivational …
Newswise (press release) Each participant in the study receives a smartphone preloaded with an application that uses a reward system to encourage them to proactively take their daily asthma controller medications. They also receive a free data plan (including unlimited talking … |
View full post on asthma – Google News
|
NIH-funded Study Finds 2.5 Percent of Americans Have a Food Allergy
Occupational Health & Safety An estimated 2.5 percent of Americans–7.5 million people–have at least one food allergy and young black children with asthma appear to be at the highest … Man's Best Friend Could Stave Off Childhood Eczema |
View full post on asthma – Google News
 MedIndia |
NIH-funded Study: Nearly 3 of 100 Americans Have a Food Allergy
Newswise (press release) Newswise — An estimated 2.5 percent of Americans — 7.5 million people — have at least one food allergy and young black children with asthma appear to be … Flu Shots OK for People With Egg Allergy Flu vaccine may be safe for people with egg allergies It Is Safe For People Allergic To Eggs To Have Flu Shots |
View full post on asthma – Google News
People with a particular kind of knee alignment have a greater chance of developing osteoarthritis than do those with other types of leg alignment, reported researchers supported by the National Institutes of Health.
View full post on National Institutes of Health (NIH) News Releases
A regulatory protein best known for its role in a rare genetic brain disorder also may play a critical role in cocaine addiction, according to a recent study
in rats, funded by the National Institute on Drug Abuse (NIDA), a component of
the National Institutes of Health. The study was published today in the journal
Nature Neuroscience.
View full post on National Institutes of Health (NIH) News Releases
Researchers supported by the National Institutes of Health have for the first time activated mouse egg cells at the earliest stage of their development and brought them to maturity. In a related experiment, the researchers replicated the finding by also bringing human eggs to maturity in the laboratory.
View full post on National Institutes of Health (NIH) News Releases
A team of NIH-funded researchers has successfully regenerated rabbit
joints using a cutting edge process to form the joint inside the body,
or in vivo. Regenerative in vivo procedures are performed by stimulating
previously irreparable organs or tissues to heal themselves. In this
study, bioscaffolds, or three-dimensional structures made of biocompatible
and biodegradable materials in the shape of the tissue, were infused
with a protein to promote growth of the rabbit joint.
View full post on National Institutes of Health (NIH) News Releases
A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the French National Agency for Research on AIDS and Viral Hepatitis, brings physicians closer to optimizing the treatment of severely immunosuppressed individuals with HIV-TB co-infection. The findings were presented today at the XVIII International AIDS Conference in Vienna by principal investigators Francois-Xavier Blanc, M.D., Anne E. Goldfeld, M.D., and Sok Thim, M.D.
View full post on National Institutes of Health (NIH) News Releases